Clinical Trials Directory

Trials / Completed

CompletedNCT01364207

The Effects of Caffeinated Coffee on Intraocular Pressure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
112 (actual)
Sponsor
Massachusetts Eye and Ear Infirmary · Academic / Other
Sex
All
Age
40 Years – 89 Years
Healthy volunteers
Accepted

Summary

High intraocular pressure (IOP) is a known risk factor for developing primary open-angle glaucoma (POAG). There is controversy in the literature regarding the degree to which caffeine influences IOP, with some studies reporting minimal changes in IOP while others report up to 4 mmHg increases. To date there are no double-masked randomized controlled trials that examine acute caffeinated coffee's effects on IOP in patients with or at risk for primary open-angle glaucoma. The investigators aim to better understand the relationship between acute caffeinated coffee (vs decaffeinate coffee) consumption and IOP in a double-masked, crossover randomized controlled clinical trial.

Conditions

Interventions

TypeNameDescription
OTHERCaffeinated CoffeeParticipants will drink one 8 oz cup in the morning hours. Participants have 15 minutes to drink the coffee but may do so in less time.
OTHERDecaffeinated CoffeeParticipants will drink one 8 oz cup in the morning hours. Participants have 15 minutes to drink the coffee but may do so in less time.

Timeline

Start date
2010-11-01
Primary completion
2011-08-01
Completion
2012-06-01
First posted
2011-06-02
Last updated
2012-10-31
Results posted
2012-10-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01364207. Inclusion in this directory is not an endorsement.